Welcome to the first session in the GenoMed4All & ERN-EuroBloodNet Educational program on Artificial Intelligence in hematology for public-at-large.
This is an 4-part webinar series on Artificial Intelligence and its applications in hematology targeting the public-at-large and aiming to increase awareness on the cutting-edge advances of Artificial Intelligence for the diagnosis, treatments and follow-up of three different rare hematological clinical domains. The growing role of Artificial Intelligence is thus displayed in improving care and accelerating patients’ management via personalized medicine.
Each webinar is a live session where interaction among speakers and the audience is encouraged during the closing Q&A session.
---
GenoMed4All is the European initiative to transform the response to Haematological Diseases by seizing the power of Artificial Intelligence.
Genomed4all Website: genomed4all.eu/
The content of the ERN-EuroBloodNet’s RU-vid channel is carried out within the framework of European Reference Network on Rare Haematological Diseases (ERN-EuroBloodNet)-Project ID No 101085717. ERN-EuroBloodNet is partly co-funded by the European Union within the framework of the Fourth EU Health Programme.
ERN-EuroBloodNet is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States and covers Rare Hematological Diseases (RHD). Please visit the EuroBloodNet’s website to explore different initiatives we work on and how we can support patients and health professionals in the field of (RHD). eurobloodnet.eu/
Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.
22 дек 2023
